Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PeriPREVENT: CO2 Injection vs Iodinated Contrast for PVI in Patients at Risk for CA-AKI
NCT06656988Phase 3Recruiting
- Sponsor
- Leipzig University
- Start
- Apr 2025
- Primary completion
- Feb 2028
- Modality
- Inhalation Devices
- Countries
- 2
01
Overview
A Phase 3 trial of Carbon dioxide in contrast-associated acute kidney injury (CA-AKI), sponsored by Leipzig University. Started Apr 2025; status: recruiting.
02
Drugs
Carbon dioxide
03
Conditions
contrast-associated acute kidney injury (CA-AKI)
Beyond the preview
Go deeper on NCT06656988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06656988.